Arterial stiffness is not associated with bone parameters in an elderly hyperhomocysteinemic population.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 25804313)

Published in J Bone Miner Metab on March 25, 2015

Authors

S C van Dijk1, R T de Jongh2,3, A W Enneman4, A C Ham4, K M A Swart3, J P van Wijngaarden5, N L van der Zwaluw5, E M Brouwer-Brolsma5, N M van Schoor3, R A M Dhonukshe-Rutten5, P Lips2,3, C P G M de Groot5, Y M Smulders2,6, H J Blom6,7, E J Feskens5, J M Geleijnse5, A H van den Meiracker4, F U S Mattace Raso4, A G Uitterlinden4,8, M C Zillikens4, N van der Velde4,9

Author Affiliations

1: Section of Geriatrics, Department of Internal Medicine, Erasmus Medical Center, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. s.c.vandijk@erasmusmc.nl.
2: Department of Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands.
3: Department of Epidemiology and Biostatistics, EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands.
4: Section of Geriatrics, Department of Internal Medicine, Erasmus Medical Center, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.
5: Division of Human Nutrition, Wageningen University, Wageningen, The Netherlands.
6: Institute for Cardiovascular Research ICaR-VU, VU University Medical Center, Amsterdam, The Netherlands.
7: Department of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands.
8: Netherlands Consortium of Healthy Ageing, Rotterdam and Leiden, The Netherlands.
9: Section of Geriatrics, Department of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands.

Articles cited by this

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86

Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation (2006) 8.18

A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med (2012) 6.85

Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem (2004) 4.31

Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens (2012) 3.73

Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med (2004) 3.32

Cardiovascular diseases and risk of hip fracture. JAMA (2009) 2.69

Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ (2004) 2.59

Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation (2001) 2.59

Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res (2005) 2.49

Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ (2009) 2.46

Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine. Circulation (2003) 2.30

Heart failure is a risk factor for orthopedic fracture: a population-based analysis of 16,294 patients. Circulation (2008) 1.98

Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation (2001) 1.69

Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? Endocrine (2004) 1.64

Homocysteine level is associated with aortic stiffness in elderly: cross-sectional results from the B-PROOF study. J Hypertens (2013) 1.52

Bone mineral density and stroke. Stroke (2003) 1.52

Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip. J Intern Med (2006) 1.49

The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease. Expert Rev Cardiovasc Ther (2006) 1.34

The association of bone mineral density measures with incident cardiovascular disease in older adults. Osteoporos Int (2007) 1.19

Peripheral arterial disease is associated with higher rates of hip bone loss and increased fracture risk in older men. Circulation (2009) 1.14

Cardiovascular disease and osteoporosis. J Endocrinol Invest (2005) 1.12

Volumetric and areal bone mineral density measures are associated with cardiovascular disease in older men and women: the health, aging, and body composition study. Calcif Tissue Int (2006) 1.12

The link between osteoporosis and cardiovascular disease. Clin Cases Miner Bone Metab (2008) 1.08

(Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis. Arthritis Res Ther (2011) 1.07

Vascular calcification in middle age and long-term risk of hip fracture: the Framingham Study. J Bone Miner Res (2007) 1.02

Rationale and design of the B-PROOF study, a randomized controlled trial on the effect of supplemental intake of vitamin B12 and folic acid on fracture incidence. BMC Geriatr (2011) 1.00

Elevated arterial stiffness in postmenopausal women with osteoporosis. Maturitas (2006) 0.99

Hip fracture risk in statin users--a population-based Danish case-control study. Osteoporos Int (2004) 0.99

Increased pulse wave velocity associated with reduced calcaneal quantitative osteo-sono index: possible relationship between atherosclerosis and osteopenia. J Clin Endocrinol Metab (2003) 0.94

Association between lumbar bone mineral density and vascular stiffness as assessed by pulse wave velocity in postmenopausal women. J Bone Miner Metab (2008) 0.91

Relationship between carotid atherosclerosis and lumbar spine bone mineral density in postmenopausal women. Hypertens Res (2008) 0.89

Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations. Eur J Clin Nutr (2005) 0.89

Low bone mineral density and mortality in men and women: the Third National Health and Nutrition Examination Survey linked mortality file. Ann Epidemiol (2008) 0.87

Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone. Bone (2008) 0.85

Hyperhomocysteinemia: a biochemical link between bone and cardiovascular system diseases? J Endocrinol Invest (2009) 0.84

Calcaneal osteopenia is a new marker for arterial stiffness in chronic hemodialysis patients. Am J Nephrol (2005) 0.84

Effect of Vitamin B12 and Folic Acid Supplementation on Bone Mineral Density and Quantitative Ultrasound Parameters in Older People with an Elevated Plasma Homocysteine Level: B-PROOF, a Randomized Controlled Trial. Calcif Tissue Int (2015) 0.83

Homocysteine modulates the proteolytic potential of human arterial smooth muscle cells through a reactive oxygen species dependant mechanism. Mol Cell Biochem (2009) 0.83

Role of OPG/RANKL/RANK axis on the vasculature. Histol Histopathol (2008) 0.83

Increased augmentation index and central aortic blood pressure in osteoporotic postmenopausal women. Osteoporos Int (2007) 0.81

Effects of 2-year vitamin B12 and folic acid supplementation in hyperhomocysteinemic elderly on arterial stiffness and cardiovascular outcomes within the B-PROOF trial. J Hypertens (2015) 0.78

The effect of ankle oedema on bone ultrasound assessment at the heel. Osteoporos Int (1997) 0.78

Association between bone mineral density and arterial stiffness in hypertensive patients. Tohoku J Exp Med (2011) 0.77